(71) performed the first panel-based NGS study in nine patients with chordoma for the mutations of 48 cancer genes, but failed to identify somatic mutations in “hotspots” of genes known to be involved in cancer development; very low mutation rates of KDR, KIT, and TP53 were determined. Here, KDR is linked to cancer.